Published Research
Published Research
Next-Gen Cell Therapies
Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells
Weill Cornell Medicine
In Vivo Immune Engineering
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
September 4, 2026Dana-Farber Cancer Institute, The University of Pennsylvania, University of California, Los Angeles, University of California, San Francisco, The University of Texas MD Anderson Cancer Center
Neoantigen-Driven Targeting
Intratumoral CD4 + T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
September 4, 2026University of California, San Francisco
Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
May 25, 2020University of California, San Francisco
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
April 27, 2020Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies
April 16, 2020University of California, San Francisco
CRISPR-engineered T cells in Patients with Refractory Cancer
February 28, 2020The University of Pennsylvania
ILC2s amplify PD-1 Blockade by Activating Tissue-specific Cancer Immunity
February 19, 2020B cells and tertiary lymphoid structures promote immunotherapy response
January 15, 2020The University of Texas MD Anderson Cancer Center